X-53201727-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_004187.5(KDM5C):c.1884G>A(p.Gln628Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00157 in 1,210,494 control chromosomes in the GnomAD database, including 30 homozygotes. There are 508 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0080 ( 11 hom., 238 hem., cov: 23)
Exomes 𝑓: 0.00091 ( 19 hom. 270 hem. )
Consequence
KDM5C
NM_004187.5 synonymous
NM_004187.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.77
Genes affected
KDM5C (HGNC:11114): (lysine demethylase 5C) This gene is a member of the SMCY homolog family and encodes a protein with one ARID domain, one JmjC domain, one JmjN domain and two PHD-type zinc fingers. The DNA-binding motifs suggest this protein is involved in the regulation of transcription and chromatin remodeling. Mutations in this gene have been associated with X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant X-53201727-C-T is Benign according to our data. Variant chrX-53201727-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 129375.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.77 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00802 (901/112368) while in subpopulation AFR AF= 0.0277 (857/30933). AF 95% confidence interval is 0.0262. There are 11 homozygotes in gnomad4. There are 238 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM5C | NM_004187.5 | c.1884G>A | p.Gln628Gln | synonymous_variant | 14/26 | ENST00000375401.8 | NP_004178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM5C | ENST00000375401.8 | c.1884G>A | p.Gln628Gln | synonymous_variant | 14/26 | 1 | NM_004187.5 | ENSP00000364550.4 |
Frequencies
GnomAD3 genomes AF: 0.00794 AC: 892AN: 112314Hom.: 11 Cov.: 23 AF XY: 0.00667 AC XY: 230AN XY: 34458
GnomAD3 genomes
AF:
AC:
892
AN:
112314
Hom.:
Cov.:
23
AF XY:
AC XY:
230
AN XY:
34458
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00254 AC: 464AN: 182732Hom.: 12 AF XY: 0.00171 AC XY: 115AN XY: 67254
GnomAD3 exomes
AF:
AC:
464
AN:
182732
Hom.:
AF XY:
AC XY:
115
AN XY:
67254
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000908 AC: 997AN: 1098126Hom.: 19 Cov.: 31 AF XY: 0.000743 AC XY: 270AN XY: 363488
GnomAD4 exome
AF:
AC:
997
AN:
1098126
Hom.:
Cov.:
31
AF XY:
AC XY:
270
AN XY:
363488
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00802 AC: 901AN: 112368Hom.: 11 Cov.: 23 AF XY: 0.00689 AC XY: 238AN XY: 34522
GnomAD4 genome
AF:
AC:
901
AN:
112368
Hom.:
Cov.:
23
AF XY:
AC XY:
238
AN XY:
34522
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 08, 2013 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 30, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at